Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
Authors
Keywords
Guideline, Antiviral prophylaxis, Hepatitis B, Cancer treatment
Journal
ANNALS OF HEMATOLOGY
Volume 94, Issue 9, Pages 1441-1450
Publisher
Springer Nature
Online
2015-07-20
DOI
10.1007/s00277-015-2447-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevention of Hepatitis B Virus Reactivation With Lamivudine in a Patient With Advanced Renal Cell Carcinoma Treated With Everolimus
- (2016) Carmine DʼAniello et al. AMERICAN JOURNAL OF THERAPEUTICS
- Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results
- (2015) M. L. Wang et al. BLOOD
- American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
- (2015) K. Rajender Reddy et al. GASTROENTEROLOGY
- Hepatitis C infection is associated with hepatic toxicity but does not compromise the survival of patients with diffuse large B cell lymphoma treated with rituximab-based chemotherapy
- (2015) Tzu-Ting Chen et al. LEUKEMIA RESEARCH
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
- (2015) JOURNAL OF HEPATOLOGY
- High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia
- (2015) Chien-Yuan Chen et al. PLoS One
- Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM)
- (2014) P. Pedrazzoli et al. ANNALS OF ONCOLOGY
- European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
- (2014) M. Engelhardt et al. HAEMATOLOGICA
- Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study
- (2014) Wai-Kay Seto et al. JOURNAL OF CLINICAL ONCOLOGY
- Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis
- (2013) F. Cervantes et al. BLOOD
- Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature
- (2013) Eleonora Teplinsky et al. BREAST CANCER RESEARCH AND TREATMENT
- Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours
- (2013) W H Y Ling et al. BRITISH JOURNAL OF CANCER
- Prophylaxis against hepatitis B reactivation among patients with lymphoma receiving rituximab
- (2013) Joseph Adrian Lumawig Buensalido et al. Expert Review of Anti-Infective Therapy
- BCR Signaling in Chronic Lymphocytic Leukemia and Related Inhibitors Currently in Clinical Studies
- (2013) Tadeusz Robak et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B
- (2013) Yi-Hsiang Huang et al. JOURNAL OF CLINICAL ONCOLOGY
- Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline
- (2013) Christopher R. Flowers et al. JOURNAL OF CLINICAL ONCOLOGY
- European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN
- (2013) D. Engelhard et al. Transplant Infectious Disease
- Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation—guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
- (2012) Florian Weissinger et al. ANNALS OF HEMATOLOGY
- Hepatitis B Virus Screening Before Chemotherapy for Lymphoma: A Cost-Effectiveness Analysis
- (2012) Urszula Zurawska et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of 2009 pandemic H1N1 influenza vaccination in adults with lymphoid malignancies receiving chemotherapy or following autologous stem cell transplant
- (2012) Diego Villa et al. LEUKEMIA & LYMPHOMA
- Varicella Zoster Virus Infection during Chemotherapy in Solid Cancer Patients
- (2012) Seung Tae Kim et al. ONCOLOGY
- Hepatitis B virus management to prevent reactivation after chemotherapy: a review
- (2012) Jessica P. Hwang et al. SUPPORTIVE CARE IN CANCER
- Management of hepatitis B reactivation in patients receiving cancer chemotherapy
- (2012) Yi-Wen Huang et al. Therapeutic Advances in Gastroenterology
- Response to influenza virus vaccination during chemotherapy in patients with breast cancer
- (2011) A. Meerveld-Eggink et al. ANNALS OF ONCOLOGY
- Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study
- (2011) B. Rousseau et al. ANNALS OF ONCOLOGY
- Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
- (2011) M. H. Buch et al. ANNALS OF THE RHEUMATIC DISEASES
- Reporting of long-term extension studies: lack of consistency calls for consensus
- (2011) M. H. Buch et al. ANNALS OF THE RHEUMATIC DISEASES
- Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy
- (2011) J Yun et al. BRITISH JOURNAL OF CANCER
- Guidelines on the investigation and management of follicular lymphoma
- (2011) Christopher McNamara et al. BRITISH JOURNAL OF HAEMATOLOGY
- Efficacy of Continuous, Daily, Oral, Ultra-low-dose 200 mg Acyclovir to Prevent Herpes Zoster Events Among Bortezomib-treated Patients: A Report From Retrospective Study
- (2011) T. Aoki et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- An Argument for the Universal Prophylaxis of Hepatitis B Infection in Patients Receiving Rituximab: A 7-Year Institutional Experience of Hepatitis Screening
- (2011) C. Leung et al. ONCOLOGIST
- Onset and complications of varicella zoster reactivation in the autologous hematopoietic cell transplant population
- (2011) J.E. Rogers et al. Transplant Infectious Disease
- Severe novel influenza A (H1N1) infection in cancer patients
- (2010) L. A. Hajjar et al. ANNALS OF ONCOLOGY
- Prevention and treatment of pandemic influenza in cancer patients
- (2010) D. Francisci et al. ANNALS OF ONCOLOGY
- Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
- (2010) A. M. Evens et al. ANNALS OF ONCOLOGY
- HBV disease: HBsAg carrier and occult B infection reactivation in haematological setting
- (2010) Carlo Marinone et al. DIGESTIVE AND LIVER DISEASE
- Rituximab
- (2010) Gillian M. Keating DRUGS
- Recommendations for identification and public health management of persons with chronic hepatitis B virus infection
- (2010) Cindy M. Weinbaum et al. HEPATOLOGY
- American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases
- (2010) Andrew S. Artz et al. JOURNAL OF CLINICAL ONCOLOGY
- Utility of Influenza Vaccination for Oncology Patients
- (2010) Daniel A. Pollyea et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy
- (2010) Jorge Méndez-Navarro et al. LIVER INTERNATIONAL
- How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation
- (2009) R. Liang BLOOD
- How I treat influenza in patients with hematologic malignancies
- (2009) C. Casper et al. BLOOD
- Antiviral prophylaxis in haematological patients: Systematic review and meta-analysis
- (2009) Dafna Yahav et al. EUROPEAN JOURNAL OF CANCER
- Prevention of hepatitis B virus reactivation under rituximab therapy
- (2009) Yutaka Tsutsumi et al. Immunotherapy
- Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
- (2009) Ken M Kunisaki et al. LANCET INFECTIOUS DISEASES
- Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project
- (2009) Kenneth R Carson et al. LANCET ONCOLOGY
- Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia
- (2008) J Styczynski et al. BONE MARROW TRANSPLANTATION
- Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy
- (2008) Eric Vickrey et al. CANCER
- Analysis of Herpes Zoster Events Among Bortezomib-Treated Patients in the Phase III APEX Study
- (2008) Asher Chanan-Khan et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab
- (2008) Winnie Yeo et al. JOURNAL OF CLINICAL ONCOLOGY
- Lung infections after cancer chemotherapy
- (2008) Sandro Vento et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now